Literature DB >> 1765134

Role of genetic variability in neonatal jaundice. A prospective study on full-term, blood group-compatible infants.

N Lucarini1, F Gloria-Bottini, L Tucciarone, E Carapella, G Maggioni, E Bottini.   

Abstract

A series of genetic, developmental and environmental variables have been analyzed in a prospective sample of full-term newborn babies, compatible with their mothers in the major blood group systems, in order to attempt an evaluation of the effect of these variables on serum bilirubin level during the first few days of life. Three genetic factors (PGM1, ACP1 and ADA) and three non-genetic variables (rise of bilirubin level during the first day of life, a mother with a history of previous abortion, and use of alcoholic beverages by the mother) have a significant predictive value for the separation of newborns with clinically relevant jaundice from other infants.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1765134     DOI: 10.1007/bf01918389

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  10 in total

1.  GENETICAL STUDIES ON HUMAN RED CELL ACID PHOSPHATASE.

Authors:  D A HOPKINSON; N SPENCER; H HARRIS
Journal:  Am J Hum Genet       Date:  1964-03       Impact factor: 11.025

2.  PHOSPHOGLUCOMUTASE POLYMORPHISM IN MAN.

Authors:  N SPENCER; D A HOPKINSON; H HARRIS
Journal:  Nature       Date:  1964-11-21       Impact factor: 49.962

3.  Comparative activity of red cell adenosine deaminase allelic forms.

Authors:  G Battistuzzi; R Scozzari; P Santolamazza; L Terrenato; G Modiano
Journal:  Nature       Date:  1974-10-25       Impact factor: 49.962

4.  Human phosphoglucomutase locus 1: red cell enzymatic activities associated with common isoelectric focusing phenotypes.

Authors:  R Scacchi; R M Corbo; R Palmarino; G Sacco; M Arnone; P Lucarelli
Journal:  Hum Hered       Date:  1983       Impact factor: 0.444

5.  ACP1GUA-1--a low-activity variant of human erythrocyte acid phosphatase: association with increased glutathione reductase activity.

Authors:  H W Mohrenweiser; J E Novotny
Journal:  Am J Hum Genet       Date:  1982-05       Impact factor: 11.025

6.  Letter: Neonatal jaundice and erythrocyte-acid-phosphatase phenotype.

Authors:  E Bottini; R Scacchi; F Gloria-Bottini; J Mortera; R Palmarino; E Carapella-De-Luca; A S Lapi; C Nodari
Journal:  Lancet       Date:  1976-04-24       Impact factor: 79.321

7.  Interaction between placental alkaline phosphatase and ABO system polymorphisms. Effects on the clinical manifestations of feto-maternal ABO incompatibility.

Authors:  E Bottini; P Lucarelli; M Orzalesi; R Palmarino; M Di Mino; F Gloria; L Terrenato; G F Spennati
Journal:  Vox Sang       Date:  1972       Impact factor: 2.144

8.  Genetically determined variation of adenylate kinase in man.

Authors:  R A Fildes; H Harris
Journal:  Nature       Date:  1966-01-15       Impact factor: 49.962

9.  Genetics of the alkaline phosphatase polymorphism of the human placenta.

Authors:  E B Robson; H Harris
Journal:  Nature       Date:  1965-09-18       Impact factor: 49.962

10.  Phenotype dependence in the inhibition of red cell acid phosphatase (ACP) by folates.

Authors:  G F Sensabaugh; V L Golden
Journal:  Am J Hum Genet       Date:  1978-09       Impact factor: 11.025

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.